Jørn V.
Sagen
Associate professor II
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 55 97 61 74
E-mail:
Journal articles
- 2014. Weight cycling promotes fat gain and altered clock gene expression in adipose tissue in C57BL/6J mice. American Journal of Physiology. Endocrinology and Metabolism. 306: E210-E224. doi: 10.1152/ajpendo.00188.2013
- 2014. COL6A3 expression in adipocytes associates with insulin resistance and depends on PPARγ and adipocyte size. Obesity. 22: 1807-1813. doi: 10.1002/oby.20758
- 2014. GCK-MODY diabetes as a protein misfolding disease: The mutation R275C promotes protein misfolding, self-association and cellular degradation. Molecular and Cellular Endocrinology. 382: 55-65. doi: 10.1016/j.mce.2013.08.020
- 2013. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. American Journal of Human Genetics. 93: 150-157. doi: 10.1016/j.ajhg.2013.05.023
- 2013. Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of MCF-7 breast cancer cells. PLoS ONE. 8. 10 pages. doi: 10.1371/journal.pone.0070096
- 2013. cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1. Endocrinology. 154: 1513-1527. doi: 10.1210/en.2012-2049
- 2013. AICAR regulates G6Pase independently of SRC-2/ROR alpha. Diabetologia. 56: S281-S281.
- 2013. Monogenetic diabetes mellitus in Norway :. Norsk Epidemiologi. 23: 55-60.
- 2013. Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. Molecular Endocrinology. 27: 366-380. doi: 10.1210/me.2012-1324
- 2012. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. International Journal of Obesity. 36: 1195-1202. doi: 10.1038/ijo.2011.240
- 2012. Ablation of Steroid Receptor Coactivator-3 Resembles the Human CACT Metabolic Myopathy. Cell Metabolism. 15: 752-763. doi: 10.1016/j.cmet.2012.03.020
- 2011. Nuclear hormone receptors – a family of hormone dependent transcriptional regulators. Klinisk kemi i Norden. 23: 30-35.
- 2010. Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS ONE. 5. 12 pages. doi: 10.1371/journal.pone.0011033
- 2010. From stress response to developmental processes in abdominal subcutaneous adipose tissue after bariatric surgery. Endocrine journal. 57: S429-S429.
- 2010. cAMP-mediated regulation of HNF-4 alpha depends on the level of coactivator PGC-1 alpha. Biochimica et Biophysica Acta. Molecular Cell Research. 1803: 1013-1019. doi: 10.1016/j.bbamcr.2010.05.008
- 2010. Gene Expression Profile of Nuclear Receptors and Coregulators in Adipose Tissues in Morbid Obesity and after Profound Fat Loss. Endocrine reviews. 31. 1 pages.
- 2010. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proceedings of the National Academy of Science of the United States of America. 107: 11122-11127. doi: 10.1073/pnas.1005262107
- 2008. Recruitment of coactivator glucocorticoid receptor interacting protein 1 to an estrogen receptor transcription complex is regulated by the 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase. Endocrinology. 149: 4336-4345. doi: 10.1210/en.2008-0037
- 2008. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry. Pediatric Diabetes. 9: 442-449. doi: 10.1111/j.1399-5448.2008.00399.x
- 2007. Management of neonatal and infancy-onset diabetes mellitus. Endocrine Development. 11: 94-105.
- 2006. A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes - Studies of HNF4A variants in the Norwegian MODY registry. Diabetes. 55: 1899-1903. doi: 10.2337/db05-1677
- 2006. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nature Genetics. 38: 54-62. doi: 10.1038/ng1708
- 2006. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation. Diabetes. 55: 1713-1722.
- 2005. Molekylærgenetisk diagnostikk ved diabetes mellitus. Tidsskrift for Den norske legeforening. 125: 2968-2972.
- 2005. Molekylærgenetisk diagnostikk ved diabetes mellitus. Tidsskrift for Den norske legeforening. 125: 2968-2972.
- 2005. Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus. Diabetic Medicine. 22: 1012-1015.
- 2005. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1 alpha mutation carriers. Diabetic Medicine. 22: 406-409.
- 2004. A gel electrophoresis method for detection of mitochondrial DNA mutation (3243 tRNA (Leu (UUR))) applied to a Norwegian family with diabetes mellitus and hearing loss. Scandinavian Journal of Clinical and Laboratory Investigation. 64: 86-92.
- 2004. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2 - Patient characteristics and initial response to sulfonylurea therapy. Diabetes. 53: 2713-2718.
- 2003. Hepatocyte nuclear factor- 1 alpha gene mutations and diabetes in Norway. Journal of Clinical Endocrinology and Metabolism. 88: 920-931.
- 2003. Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway. Journal of Clinical Endocrinology and Metabolism. 88: 920-931.
- 2003. Klinisk molekylærmedisin (4): Koblingsanalyser. Pediatrisk Endokrinologi. 16: 34-38.
- 2003. Permanent neonatal diabetes caused by glucokinase deficiency; inborn error of the glucose-insulin signaling pathway. Diabetes. 52: 2854-2860.
- 2003. Enlarged nephrons and severe non-diabetic nephropathy in hepatocyte nuclear factor (HNF)-1 beta mutation carriers. Kidney International. 64: 793-800.
- 2003. Enlarged nephrons and severe non-diabetic nephropathy in hepatocyte nuclear factor (HNF)-1 beta mutation carriers. Kidney International. 64: 793-800.
- 2002. Reduced prevalence of late-diabetic complications in MODY3 with early diagnosis. Diabetic Medicine. 19: 697-703.
- 1998. Ikke-insulinkrevende diabetes mellitus hos barn og unge voksne. Tidsskrift for Den norske legeforening. 118: 1054-1057.
- 1998. Hyperexacitability to sulphonylurea in MODY3. Diabetologia. 41: 607-608.
Reports and theses
- 2005. Clinical and molecular aspects of monogenic diabetes mellitus.
Book sections
- 2011. Steroid Receptor Coactivators and Endocrine Treatment in Breast Cancer. 2, pages 35-66. In:
- 2011. Nuclear Receptors. Nova Science Publishers, Inc.. 174 pages. ISBN: 978-1-61209-980-4.
- 2011. Fysisk aktivitet. 5, pages 147-157. In:
- 2011. Diabetes : forebygging, oppfølging, behandling. Akribe Forlag. 374 pages. ISBN: 978-82-7950-074-2.
- 2011. Sykdomslære. 1, pages 19-73. In:
- 2011. Diabetes : forebygging, oppfølging, behandling. Akribe Forlag. 374 pages. ISBN: 978-82-7950-074-2.
- 2008. MODY5 due to mutations in TCF2 (HNF-1ß): The clinical spectrum with special reference to urogenital malformations. Kapittel, pages 1096-1102. In:
- 2008. Inborn Errors of Development. Oxford University Press. 1664 pages. ISBN: 9780195306910.
More information in national current research information system (CRIStin)
